Helix BioPharma Corp.
-
Ticker
HBP
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 11-50 Employees
- Based in Richmond Hill, Ontario
Helix BioPharma Corp. is an immuno-oncology company specializing in the field of cancer therapy. Helix is a biopharmaceutical company developing unique therapies in the field of immuno-oncology, for the prevention and treatment of cancer, based on its proprietary technology platform DOS47. Helix is currently listed on the TSX under the symbol “HBP”.
REPORT RATINGS
4.8 / 5.0 (97)
Helix BioPharma Corp. reports have an aggregate usefulness score of 4.8 based on 97 reviews.
Helix BioPharma Corp.
Most Recent Annual Report
MOST RECENT
2022 Annual Report
Older/Archived Annual Reports